MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases

TY - JOUR

T1 - MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases

A1 - Filippi,Beatrice M.

A1 - de los Heros,Paola

A1 - Mehellou,Youcef

A1 - Navratilova,Iva

A1 - Gourlay,Robert

A1 - Deak,Maria

A1 - Plater,Lorna

A1 - Toth,Rachel

A1 - Zeqiraj,Elton

A1 - Alessi,Dario R.

AU - Filippi,Beatrice M.

AU - de los Heros,Paola

AU - Mehellou,Youcef

AU - Navratilova,Iva

AU - Gourlay,Robert

AU - Deak,Maria

AU - Plater,Lorna

AU - Toth,Rachel

AU - Zeqiraj,Elton

AU - Alessi,Dario R.

PY - 2011/5/4

Y1 - 2011/5/4

N2 - <p>Mouse protein-25 (MO25) isoforms bind to the STRAD pseudokinase and stabilise it in a conformation that can activate the LKB1 tumour suppressor kinase. We demonstrate that by binding to several STE20 family kinases, MO25 has roles beyond controlling LKB1. These new MO25 targets are SPAK/OSR1 kinases, regulators of ion homeostasis and blood pressure, and MST3/MST4/YSK1, involved in controlling development and morphogenesis. Our analyses suggest that MO25 alpha and MO25 beta associate with these STE20 kinases in a similar manner to STRAD. MO25 isoforms induce approximately 100-fold activation of SPAK/OSR1 dramatically enhancing their ability to phosphorylate the ion cotransporters NKCC1, NKCC2 and NCC, leading to the identification of several new phosphorylation sites. siRNA-mediated reduction of expression of MO25 isoforms in mammalian cells inhibited phosphorylation of endogenous NKCC1 at residues phosphorylated by SPAK/OSR1, which is rescued by re-expression of MO25 alpha. MO25 alpha/beta binding to MST3/MST4/YSK1 also stimulated kinase activity three-to four-fold. MO25 has evolved as a key regulator of a group of STE20 kinases and may represent an ancestral mechanism of regulating conformation of pseudokinases and activating catalytically competent protein kinases. The EMBO Journal (2011) 30, 1730-1741. doi:10.1038/emboj.2011.78; Published online 18 March 2011</p>

AB - <p>Mouse protein-25 (MO25) isoforms bind to the STRAD pseudokinase and stabilise it in a conformation that can activate the LKB1 tumour suppressor kinase. We demonstrate that by binding to several STE20 family kinases, MO25 has roles beyond controlling LKB1. These new MO25 targets are SPAK/OSR1 kinases, regulators of ion homeostasis and blood pressure, and MST3/MST4/YSK1, involved in controlling development and morphogenesis. Our analyses suggest that MO25 alpha and MO25 beta associate with these STE20 kinases in a similar manner to STRAD. MO25 isoforms induce approximately 100-fold activation of SPAK/OSR1 dramatically enhancing their ability to phosphorylate the ion cotransporters NKCC1, NKCC2 and NCC, leading to the identification of several new phosphorylation sites. siRNA-mediated reduction of expression of MO25 isoforms in mammalian cells inhibited phosphorylation of endogenous NKCC1 at residues phosphorylated by SPAK/OSR1, which is rescued by re-expression of MO25 alpha. MO25 alpha/beta binding to MST3/MST4/YSK1 also stimulated kinase activity three-to four-fold. MO25 has evolved as a key regulator of a group of STE20 kinases and may represent an ancestral mechanism of regulating conformation of pseudokinases and activating catalytically competent protein kinases. The EMBO Journal (2011) 30, 1730-1741. doi:10.1038/emboj.2011.78; Published online 18 March 2011</p>

KW - Kinase activation

KW - STE20 kinases

KW - WNK1

KW - WNK4

U2 - 10.1038/emboj.2011.78

DO - 10.1038/emboj.2011.78

M1 - Article

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 9

VL - 30

SP - 1730

EP - 1741

ER -